ArticleFuture oncology (London, England)2025
Indirect treatment comparison of momelotinib vs fedratinib safety in patients with myelofibrosis.
Lucia Masarova et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it